π§ SARR β SEGMENT 1
TOPIC: OVERVIEW OF INFLAMMATION β Definition, Purpose & Core Logic
β Q1. What is inflammation?
A:
Inflammation is a protective response of vascularized tissues to infection and tissue injury, designed to deliver host defense cells and plasma proteins from the blood to the site of damage.
β Q2. Why is inflammation considered a protective response?
A:
Because it enables the body to:
- Eliminate microbes and toxins
- Remove necrotic (dead) tissue
- Initiate tissue repair
Without inflammation, survival is not possible.
β Q3. Why is inflammation often misunderstood as harmful?
A:
Because inflammation can cause:
- Pain
- Swelling
- Tissue damage
However, this damage is a by-product of defense, not the primary goal.
β Q4. What would happen if inflammation did not exist?
A:
- Infections would persist unchecked
- Wounds would fail to heal
- Injured tissues would remain chronically damaged
- Death would occur even from minor injuries
β Q5. What does inflammation aim to eliminate? (Two targets)
A:
- The primary cause of injury
- Microbes
- Toxins
- The consequences of injury
- Necrotic cells
- Damaged tissue
β‘οΈ Inflammation removes both the insult AND its aftermath.
β Q6. Which components carry out inflammatory defense?
A:
- Phagocytic leukocytes (neutrophils, macrophages)
- Antibodies
- Complement proteins
β Q7. Why are most inflammatory components kept inactive in blood?
A:
To:
- Prevent unnecessary damage to normal tissues
- Allow rapid, controlled activation only when needed
This is a key safety mechanism.
β Q8. Are all immune cells circulating in blood?
A:
No. Some immune cells:
- Reside permanently in tissues
- Act as sentinels
- Constantly monitor for:
- Microbes
- Tissue injury
β Q9. What is the core function of the inflammatory process?
A:
To:
- Deliver leukocytes and plasma proteins to sites of injury
- Activate them locally so they can:
- Destroy harmful agents
- Clear dead tissue
β‘οΈ Activation is localized, not systemic, under normal conditions.
β Q10. Why must inflammatory activation remain localized?
A:
Because systemic activation would:
- Damage healthy tissues
- Lead to life-threatening systemic inflammation
π EXAM LOCK β ONE-LINE RECALL
Inflammation is a protective, localized response of vascularized tissues that delivers and activates leukocytes and plasma proteins to eliminate injurious agents and necrotic tissue and initiate repair.
π§ CLINICAL CORRELATION (High-Yield)
- Absent or defective inflammation β recurrent infections, poor wound healing
- Excessive or misdirected inflammation β autoimmune disease, tissue destruction
π§ SARR β SEGMENT 2
TOPIC: WHAT INFLAMMATION ELIMINATES & THE DEFENSIVE COMPONENTS
β Q1. What are the TWO broad categories of things inflammation eliminates?
A:
- Injurious agents
- Damaged host tissues
Inflammation always targets both the cause and the consequence of injury.
β Q2. What are considered βinjurious agentsβ?
A:
- Infectious organisms
- Bacteria
- Viruses
- Fungi
- Parasites
- Toxins
- Exogenous (bacterial toxins, chemicals)
- Endogenous (necrotic cell products)
β Q3. What are considered βdamaged host tissuesβ?
A:
- Necrotic cells
- Dead tissue fragments
- Damaged extracellular matrix
- Cellular debris generated by:
- Trauma
- Ischemia
- Physical or chemical injury
β Q4. Why must necrotic tissue be removed?
A:
Because necrotic tissue:
- Acts as a nidus for infection
- Releases DAMPs (damage-associated molecular patterns)
- Perpetuates inflammation if not cleared
- Prevents effective tissue repair
β Q5. Which THREE major systems mediate inflammatory defense?
A:
- Leukocytes
- Plasma proteins
- Resident tissue cells
β Q6. Which leukocytes are most important in inflammation?
A:
- Neutrophils
- First responders
- Dominant in acute inflammation
- Macrophages
- Derived from monocytes
- Key cells in both acute and chronic inflammation
β Q7. What are the main functions of leukocytes in inflammation?
A:
- Phagocytosis of microbes and debris
- Killing of pathogens
- Reactive oxygen species
- Lysosomal enzymes
- Cytokine production
- Amplifies and regulates inflammation
β Q8. Which plasma proteins participate in inflammation?
A:
- Antibodies
- Complement system
- Coagulation and kinin systems (supportive roles)
β Q9. What is the role of complement in inflammation?
A:
Complement contributes by:
- Opsonization (C3b)
- Leukocyte recruitment (C5a)
- Direct microbial killing (MAC)
β Q10. What role do resident tissue cells play?
A:
Resident cells act as sentinels:
- Macrophages
- Dendritic cells
- Mast cells
- Endothelial cells
They:
- Detect injury or microbes
- Release mediators
- Initiate inflammation before leukocytes arrive
π EXAM LOCK β ONE-LINE RECALL
Inflammation eliminates injurious agents and necrotic tissue using leukocytes, plasma proteins, and resident sentinel cells to clear damage and enable repair.
π§ CLINICAL CORRELATION (High-Yield)
- Failure to clear necrotic tissue β chronic inflammation
- Excess leukocyte activation β collateral tissue injury
- Complement deficiency β recurrent infections
π§ SARR β SEGMENT 3
TOPIC: ACUTE vs CHRONIC INFLAMMATION β CORE DIFFERENCES, LOGIC & EXAM TRAPS
β Q1. How is inflammation broadly classified?
A:
Inflammation is classified into:
- Acute inflammation
- Chronic inflammation
The distinction is based on time course, cellular profile, and outcome.
β Q2. What defines ACUTE inflammation?
A:
Acute inflammation is a rapid, short-duration response characterized by:
- Immediate onset (minutes to hours)
- Short duration (hours to days)
- Dominance of neutrophils
- Prominent vascular changes
β Q3. What are the TWO major components of acute inflammation?
A:
- Vascular changes
- Vasodilation
- Increased permeability
- Cellular events
- Neutrophil recruitment
- Phagocytosis
β Q4. What are the main causes of acute inflammation?
A:
- Infections (especially bacterial)
- Tissue necrosis (ischemia, trauma)
- Foreign bodies
- Immune reactions (hypersensitivity)
β Q5. What are the possible outcomes of acute inflammation? (EXAM FAVORITE)
A:
- Complete resolution
- Restoration of normal tissue
- Healing by fibrosis (scarring)
- When damage is extensive
- Progression to chronic inflammation
β Q6. What defines CHRONIC inflammation?
A:
Chronic inflammation is a prolonged inflammatory response characterized by:
- Long duration (weeks to years)
- Simultaneous inflammation, tissue destruction, and repair
- Dominance of mononuclear cells
β Q7. Which cells dominate chronic inflammation?
A:
- Macrophages (central cell)
- Lymphocytes
- Plasma cells
β οΈ Neutrophils are not dominant in chronic inflammation.
β Q8. What are the THREE major features of chronic inflammation?
A:
- Persistent inflammatory cell infiltrate
- Ongoing tissue destruction
- Attempts at healing
- Angiogenesis
- Fibrosis
β Q9. What causes chronic inflammation?
A:
- Persistent infections
- Mycobacterium tuberculosis
- Fungi
- Autoimmune diseases
- Rheumatoid arthritis
- Prolonged exposure to toxic agents
- Silica
- Lipids (atherosclerosis)
β Q10. What is the KEY LOGIC difference between acute and chronic inflammation?
A:
- Acute inflammation aims at rapid elimination and resolution
- Chronic inflammation reflects failure to eliminate the cause
π EXAM LOCK β TABLE MEMORY (IN WORDS)
- Acute β fast, neutrophils, edema, resolution or scar
- Chronic β slow, macrophages + lymphocytes, tissue destruction + fibrosis
π§ CLINICAL CORRELATION (High-Yield)
- TB, sarcoidosis β chronic inflammation
- Acute appendicitis β acute inflammation
- Rheumatoid arthritis β chronic inflammatory disease
- Recurrent acute episodes β may evolve into chronic inflammation
π§ SARR β SEGMENT 4
TOPIC: VASCULAR CHANGES IN ACUTE INFLAMMATION β MECHANISM, LOGIC & EXAM TRAPS
β Q1. What is the FIRST vascular event in acute inflammation?
A:
A brief, transient vasoconstriction of arterioles.
- Lasts seconds
- Has no major clinical significance
- Often ignored in exams
β Q2. What is the MOST IMPORTANT vascular change in acute inflammation?
A:
Vasodilation of arterioles and capillary beds.
This is the key event.
β Q3. What causes vasodilation in acute inflammation?
A:
Primarily mediated by:
- Histamine
- Nitric oxide (NO)
Released from:
- Mast cells
- Endothelial cells
β Q4. What are the CONSEQUENCES of vasodilation?
A:
- β Blood flow to the affected area (hyperemia)
- Produces:
- Redness (rubor)
- Heat (calor)
β Q5. What is increased vascular permeability?
A:
Leakage of protein-rich plasma fluid from the intravascular space into the extravascular tissue.
This fluid is called exudate.
β Q6. Why is increased permeability important?
A:
Because it allows:
- Antibodies
- Complement proteins
- Clotting factors
to reach the site of injury.
β Q7. What are the MAIN MECHANISMS of increased vascular permeability? (EXAM CORE)
A:
- Endothelial cell contraction
- Most common mechanism
- Mediated by histamine, bradykinin, leukotrienes
- Occurs in post-capillary venules
- Rapid and reversible
- Direct endothelial injury
- Burns, toxins, severe infections
- Causes sustained leakage
- Leukocyte-mediated endothelial injury
- During adhesion and migration
- Seen in severe inflammation
β Q8. What is the difference between EXUDATE and TRANSUDATE? (FREQUENT MCQ)
A:
- Exudate
- High protein
- High cell content
- Seen in inflammation
- Transudate
- Low protein
- Few cells
- Due to β hydrostatic pressure or β oncotic pressure
- Not inflammatory
β Q9. How does fluid loss affect blood flow?
A:
- Plasma loss β β blood viscosity
- Slowing of blood flow β stasis
- Red cells become more concentrated
β Q10. Why is stasis important in inflammation?
A:
Stasis allows:
- Leukocytes to move from the center of blood flow to the vessel periphery
- This sets up leukocyte margination
β‘οΈ This is essential for leukocyte recruitment.
π EXAM LOCK β ONE-LINE RECALL
Acute inflammation causes vasodilation and increased vascular permeability, producing exudate, hyperemia, stasis, and setting the stage for leukocyte margination and migration.
π§ CLINICAL CORRELATION (High-Yield)
- Edema = fluid + protein leakage due to permeability
- Burns β direct endothelial injury β severe edema
- Hypoalbuminemia edema β transudate, not inflammation
SARR β SEGMENT 5
TOPIC: LEUKOCYTE RECRUITMENT β MARGINATION, ROLLING, ADHESION & TRANSMIGRATION
β Q1. Why must leukocytes leave the bloodstream during inflammation?
A:
Because microbes and necrotic tissue are located in the extravascular tissues, not inside blood vessels.
β Q2. Where does leukocyte recruitment mainly occur?
A:
In post-capillary venules, because:
- Blood flow is slow
- Endothelial cells respond strongly to inflammatory mediators
β Q3. What are the STEPS of leukocyte recruitment? (EXAM SEQUENCE)
A:
- Margination
- Rolling
- Firm adhesion
- Transmigration (diapedesis)
- Chemotaxis toward the site of injury
β Q4. What is margination?
A:
Movement of leukocytes from the central axial flow of blood to the peripheral endothelial surface.
Occurs due to:
- Stasis caused by plasma leakage
β Q5. What mediates leukocyte rolling?
A:
Selectins
- E-selectin (endothelial)
- P-selectin (endothelial & platelets)
- L-selectin (leukocyte)
These cause weak, transient adhesions, producing a βrollingβ motion.
β Q6. What induces selectin expression on endothelium?
A:
- TNF
- IL-1
Released from:
- Macrophages
- Mast cells
β Q7. What mediates firm adhesion of leukocytes?
A:
Integrins on leukocytes binding to:
- ICAM-1
- VCAM-1 on endothelium
Integrins are activated by chemokines.
β Q8. What is transmigration (diapedesis)?
A:
Passage of leukocytes through endothelial junctions into tissues.
Mediated by:
- PECAM-1 (CD31)
Occurs mainly in:
- Post-capillary venules
β Q9. What is chemotaxis?
A:
Directed movement of leukocytes toward higher concentrations of chemical attractants.
β Q10. What are the MAJOR chemotactic factors? (EXAM FAVORITE)
A:
- Bacterial products
- C5a
- LTB4
- IL-8
π EXAM LOCK β STEPWISE MEMORY LINE
Stasis β Margination β Selectin-mediated rolling β Integrin-mediated adhesion β PECAM-1 transmigration β Chemotaxis
π§ CLINICAL CORRELATION (High-Yield)
- Leukocyte adhesion deficiency β recurrent infections, no pus, delayed wound healing
- Anti-TNF drugs reduce leukocyte recruitment
- Steroids inhibit adhesion molecule expression
π§ SARR β SEGMENT 6
TOPIC: PHAGOCYTOSIS & LEUKOCYTE-MEDIATED TISSUE INJURY
β Q1. What is phagocytosis?
A:
Phagocytosis is the process by which leukocytes recognize, engulf, and destroy microbes and necrotic debris.
It is the central effector function of acute inflammation.
β Q2. Which cells are the main phagocytes?
A:
- Neutrophils β early, short-lived
- Macrophages β later, long-lived, dominant in chronic inflammation
β Q3. What are the STEPS of phagocytosis? (EXAM SEQUENCE)
A:
- Recognition & attachment
- Engulfment
- Killing & degradation
β Q4. How do leukocytes recognize microbes?
A:
Through:
- Opsonins coating the microbe
Main opsonins:
- IgG - FcR
- C3b - CR
- Collectins - Lectin R
These bind to specific receptors on phagocytes.
β Q5. What happens during engulfment?
A:
- The phagocyte membrane surrounds the particle
- Forms a phagosome
- Phagosome fuses with lysosome β phagolysosome
β Q6. How are microbes killed inside phagolysosomes?
A:
By two mechanisms:
1οΈβ£ Reactive oxygen species (ROS)
- Generated by NADPH oxidase
- Produces superoxide β hydrogen peroxide
- Myeloperoxidase (MPO) β hypochlorous acid (HOCl)
2οΈβ£ Nitric oxide (NO)
- Produced by inducible nitric oxide synthase (iNOS)
- Forms reactive nitrogen species, oNoo-
β Q7. What non-oxygen-dependent mechanisms kill microbes?
A:
- Lysosomal enzymes
- Defensins
- Lactoferrin
- Proteases
β Q8. What is leukocyte-mediated tissue injury?
A:
Damage to host tissues caused by:
- ROS
- Proteases
- Enzymes released from activated leukocytes
This damage is collateral, not intentional.
β Q9. When does leukocyte-mediated tissue injury occur?
A:
- During severe inflammation
- When inflammation is prolonged
- In autoimmune and hypersensitivity reactions
- When phagocytes release contents extracellularly
β Q10. How does the body limit leukocyte-mediated injury?
A:
- Antioxidants (e.g. catalase, superoxide dismutase)
- Protease inhibitors (e.g. Ξ±1-antitrypsin)
- Rapid clearance of activated leukocytes
π EXAM LOCK β ONE-LINE RECALL
Phagocytosis involves opsonin-mediated recognition, phagolysosome formation, and microbial killing by ROS and NO, with collateral host tissue injury occurring from uncontrolled leukocyte activation.
π§ CLINICAL CORRELATION (High-Yield)
- Chronic granulomatous disease β defective NADPH oxidase β recurrent infections
- Ξ±1-antitrypsin deficiency β unchecked protease activity β tissue destruction
- ARDS β neutrophil-mediated lung injury
π§ SARR β SEGMENT 7
TOPIC: TERMINATION OF ACUTE INFLAMMATION & ANTI-INFLAMMATORY MECHANISMS
β Q1. Why must inflammation be actively terminated?
A:
Because continued inflammation would:
- Cause progressive tissue damage
- Delay or prevent healing
- Lead to chronic inflammation
β‘οΈ Resolution is an active, regulated process, not passive fading.
β Q2. When does termination of acute inflammation begin?
A:
As soon as the injurious stimulus is eliminated and neutrophil influx slows.
Resolution overlaps with late acute inflammation.
β Q3. What are the MAIN MECHANISMS that terminate acute inflammation? (EXAM CORE)
A:
- Removal of the inciting stimulus
- Short half-life of inflammatory mediators
- Neutrophil apoptosis
- Switch to anti-inflammatory mediators
- Macrophage-mediated cleanup
β Q4. Why do inflammatory mediators have short half-lives?
A:
- Cytokines, prostaglandins, leukotrienes are:
- Rapidly degraded
- Produced only when stimulated
β‘οΈ Once the stimulus stops, mediator levels fall quickly.
β Q5. What happens to neutrophils during resolution?
A:
- Neutrophils undergo apoptosis
- Apoptotic neutrophils are:
- Non-inflammatory
- Rapidly phagocytosed by macrophages
β Q6. What is the role of macrophages in resolution?
A:
Macrophages:
- Clear apoptotic neutrophils
- Remove debris and necrotic tissue
- Switch phenotype from:
- Pro-inflammatory (M1) β anti-inflammatory / reparative (M2)
β Q7. Which mediators actively suppress inflammation? (EXAM FAVORITE)
A:
- IL-10
- TGF-Ξ²
- Lipoxins
- Resolvins
- Protectins
These:
- Inhibit leukocyte recruitment
- Suppress cytokine production
- Promote tissue repair
β Q8. What is mediator βclass switchingβ?
A:
A shift from:
- Pro-inflammatory mediators
- Prostaglandins
- Leukotrienes
- Anti-inflammatory mediators
- Lipoxins
- Resolvins
to:
This switch is essential for resolution.
β Q9. What are the POSSIBLE OUTCOMES after acute inflammation resolves?
A:
- Complete resolution
- Normal tissue restored
- Healing by fibrosis
- If tissue damage is extensive
- Progression to chronic inflammation
- If stimulus persists
β Q10. What causes failure of resolution?
A:
- Persistent infection
- Autoimmune reactions
- Continued exposure to toxins
- Recurrent tissue injury
β‘οΈ Leads to chronic inflammation.
π EXAM LOCK β ONE-LINE RECALL
Termination of acute inflammation is an active process involving neutrophil apoptosis, macrophage cleanup, short-lived mediators, and a switch to anti-inflammatory cytokines such as IL-10 and TGF-Ξ².
π§ CLINICAL CORRELATION (High-Yield)
- Steroids enhance resolution by inhibiting pro-inflammatory gene transcription
- Failure of resolution β chronic inflammatory diseases
- Excess TGF-Ξ² β fibrosis and organ scarring
π§ SARR β SEGMENT 8
TOPIC: SYSTEMIC EFFECTS OF INFLAMMATION β ACUTE-PHASE RESPONSE & FEVER
β Q1. What are the systemic effects of inflammation called?
A:
They are collectively called the acute-phase response.
This represents whole-body reactions to local inflammation.
β Q2. What triggers the acute-phase response?
A:
Pro-inflammatory cytokines released into the circulation:
- IL-1
- TNF
- IL-6 (most important for liver effects)
β Q3. What are the MAJOR components of the acute-phase response? (EXAM CORE)
A:
- Fever
- Acute-phase proteins
- Leukocytosis
- Constitutional symptoms
- Malaise
- Anorexia
- Somnolence
π₯ FEVER
β Q4. How does fever develop in inflammation?
A:
- IL-1 and TNF stimulate production of prostaglandin E2 (PGE2)
- PGE2 acts on the hypothalamus
- Raises the thermoregulatory set point
- Body generates heat β fever
β Q5. Why is fever beneficial?
A:
Fever:
- Inhibits growth of some microbes
- Enhances immune cell function
- Improves host defense efficiency
β Q6. Why do antipyretics reduce fever?
A:
Because drugs like paracetamol and NSAIDs:
- Inhibit cyclooxygenase
- β PGE2 synthesis
- Reset hypothalamic set point to normal
π§ͺ ACUTE-PHASE PROTEINS
β Q7. What are acute-phase proteins?
A:
Plasma proteins whose levels increase or decrease in response to inflammation.
Synthesized mainly by the liver under IL-6 stimulation.
β Q8. Which are the IMPORTANT positive acute-phase proteins? (EXAM FAVORITE)
A:
- C-reactive protein (CRP)
- Fibrinogen
- Serum amyloid A (SAA)
- Haptoglobin
- Ξ±1-antitrypsin
- Ferritin
- Procalcitonin
- Ceruloplasmin
- Complement proteins
NEGATIVE acute phase proteins
- Albumin
- Transferrin
β Q9. What are the functions of CRP?
A:
CRP:
- Binds microbes and dead cells
- Acts as an opsonin
- Activates complement
β‘οΈ Marker of acute inflammation.
β Q10. Why does ESR rise in inflammation?
A:
Because:
- β Fibrinogen β RBCs stack (rouleaux formation)
- RBCs settle faster
- ESR increases
π©Έ LEUKOCYTOSIS
β Q11. What is leukocytosis?
A:
Increase in white blood cell count in response to inflammation.
β Q12. What type of leukocytosis is seen in different conditions?
A:
- Neutrophilia β bacterial infections
- Lymphocytosis β viral infections
- Eosinophilia β parasitic infections, allergies
β Q13. What is a βleft shiftβ?
A:
Presence of immature neutrophils (bands) in blood.
Indicates acute bacterial infection.
β οΈ SEVERE SYSTEMIC INFLAMMATION
β Q14. What happens in excessive systemic inflammation?
A:
High levels of TNF and IL-1 can cause:
- Septic shock
- Hypotension
- DIC
- Metabolic abnormalities
- Multi-organ failure
β Q15. What is the key danger of uncontrolled systemic inflammation?
A:
Loss of localized control β life-threatening systemic effects.
π EXAM LOCK β ONE-LINE RECALL
The acute-phase response is driven by IL-1, TNF, and IL-6 and includes fever (via PGE2), acute-phase protein synthesis, leukocytosis, and constitutional symptoms.
π§ CLINICAL CORRELATION (High-Yield)
- CRP rises faster and normalizes quicker than ESR
- Persistently high SAA β secondary amyloidosis
- Anti-TNF therapy reduces systemic inflammatory manifestations
π§ SARR β SEGMENT 9
TOPIC: CHRONIC INFLAMMATION β MACROPHAGE ACTIVATION, CYTOKINES & TISSUE DAMAGE
β Q1. What is the DEFINING feature of chronic inflammation?
A:
Chronic inflammation is defined by persistent immune activation with:
- Ongoing inflammation
- Progressive tissue destruction
- Simultaneous repair (fibrosis + angiogenesis)
All three occur at the same time.
β Q2. Which cell is the CENTRAL regulator of chronic inflammation?
A:
The macrophage.
β‘οΈ It is the key effector, regulator, and amplifier of chronic inflammation.
β Q3. Where do macrophages in chronic inflammation come from?
A:
From:
- Circulating monocytes recruited from blood
- Resident tissue macrophages activated locally
Both contribute continuously.
β Q4. What keeps macrophages activated in chronic inflammation?
A:
Persistent stimuli:
- Microbial products (e.g. TB)
- Immune complexes
- Autoimmune reactions
- Foreign materials
- Cytokines from T lymphocytes
β Q5. What are the TWO major activation states of macrophages? (EXAM CORE)
A:
- Classically activated macrophages (M1)
- Alternatively activated macrophages (M2)
β Q6. What activates M1 macrophages?
A:
- IFN-Ξ³ from Th1 cells
- Microbial products (via TLRs)
β Q7. What are the FUNCTIONS of M1 macrophages?
A:
M1 macrophages:
- Produce pro-inflammatory cytokines (IL-1, TNF, IL-6)
- Generate ROS and NO
- Promote microbial killing
- Cause tissue damage
β‘οΈ They sustain inflammation.
β Q8. What activates M2 macrophages?
A:
- IL-4
- IL-13
(from Th2 cells)
β Q9. What are the FUNCTIONS of M2 macrophages?
A:
M2 macrophages:
- Suppress inflammation
- Promote tissue repair
- Stimulate fibrosis TGF BETA,FGF
- Enhance angiogenesis
β‘οΈ They drive healing and scarring, not killing.
β Q10. How do T lymphocytes interact with macrophages in chronic inflammation?
A:
Bidirectional loop:
- Macrophages present antigen β activate T cells
- T cells secrete cytokines β activate macrophages
- Creates a self-perpetuating inflammatory cycle
β Q11. Which T-cell subsets are important in chronic inflammation?
A:
- Th1 cells β IFN-Ξ³ β M1 activation
- Th2 cells β IL-4, IL-13 β M2 activation
- Th17 cells β IL-17 β neutrophil recruitment
β Q12. What causes tissue destruction in chronic inflammation?
A:
- ROS and NO from macrophages
- Proteases
- Persistent cytokine exposure
- Repeated cycles of injury
β Q13. Why does fibrosis occur in chronic inflammation?
A:
Because:
- Growth factors (TGF-Ξ², PDGF) are continuously released
- Fibroblasts are persistently stimulated
- Collagen deposition exceeds degradation
π EXAM LOCK β ONE-LINE RECALL
Chronic inflammation is driven by macrophageβT-cell interactions, with M1 macrophages sustaining tissue injury and M2 macrophages promoting repair and fibrosis simultaneously.
π§ CLINICAL CORRELATION (High-Yield)
- TB, sarcoidosis β macrophage-dominant chronic inflammation
- Rheumatoid arthritis β cytokine-driven synovial destruction
- Atherosclerosis β chronic inflammation to lipid antigens
- Anti-TNF therapy targets macrophage cytokine output
π§ SARR β SEGMENT 10
TOPIC: GRANULOMATOUS INFLAMMATION β STRUCTURE, MECHANISM & EXAM TRAPS
β Q1. What is granulomatous inflammation?
A:
Granulomatous inflammation is a specialized form of chronic inflammation characterized by the formation of granulomas.
β Q2. What is a granuloma?
A:
A granuloma is a compact collection of activated macrophages (epithelioid cells), often surrounded by lymphocytes.
It forms when the immune system cannot eliminate the offending agent.
β Q3. Why does the body form granulomas?
A:
To:
- Contain persistent microbes or foreign material
- Prevent their spread
- Compensate for failure of elimination
β‘οΈ Granuloma = containment strategy.
β Q4. What cells compose a typical granuloma? (EXAM CORE)
A:
- Epithelioid macrophages (activated)
- Multinucleated giant cells ( Langerhan giant cells)
- Lymphocytes (mainly T cells)
- Fibroblasts (late stages)
β Q5. What are epithelioid cells?
A:
Activated macrophages with:
- Abundant, pink cytoplasm
- Reduced phagocytic activity
- Increased secretory function
They resemble epithelial cells morphologically.
β Q6. What are multinucleated giant cells?
A:
Formed by fusion of macrophages.
Types:
- Langhans giant cells β peripheral nuclear arrangement
- Foreign body giant cells β random nuclear arrangement
β οΈ Type of giant cell is not disease-specific.
β Q7. What immune mechanism drives granuloma formation?
A:
A Th1-mediated immune response:
- Antigen β macrophage presentation
- T cells β IFN-Ξ³
- IFN-Ξ³ β macrophage activation
- Activated macrophages β granuloma formation
β Q8. What are the MAJOR CAUSES of granulomatous inflammation? (EXAM FAVORITE)
A:
- Infectious
- Tuberculosis
- Leprosy
- Fungal infections
- Non-infectious
- Sarcoidosis
- Foreign bodies (sutures)
- Crohn disease
- Berylliosis
β Q9. What is caseous necrosis and where is it seen?
A:
- A form of necrosis with cheese-like appearance
- Seen classically in tuberculosis
β οΈ Caseation is not present in all granulomas.
β Q10. What happens to granulomas over time?
A:
They may:
- Persist
- Heal by fibrosis
- Cause organ dysfunction due to mass effect or scarring
π EXAM LOCK β ONE-LINE RECALL
Granulomatous inflammation is a Th1-driven chronic inflammatory response forming granulomas to contain persistent agents that resist eradication.
π§ CLINICAL CORRELATION (High-Yield)
- TB ,Syphyllisβ caseating granulomas
- Sarcoidosis β non-caseating granulomas
- Foreign body granulomas β giant cells around inert material
- Anti-TNF therapy increases risk of TB reactivation
π§ SARR β SEGMENT 11
TOPIC: CHEMICAL MEDIATORS OF INFLAMMATION β SOURCES, ACTIONS & EXAM TRAPS
β Q1. What are chemical mediators of inflammation?
A:
Chemical mediators are substances that initiate, amplify, and regulate inflammatory reactions.
They act by:
- Increasing vascular permeability
- Causing vasodilation
- Recruiting and activating leukocytes
- Inducing tissue damage or repair
β Q2. What are the TWO major sources of inflammatory mediators? (EXAM CORE)
A:
- Cell-derived mediators
- Plasma-derived mediators
πΉ CELL-DERIVED MEDIATORS
β Q3. Which cells produce inflammatory mediators?
A:
- Mast cells
- Macrophages
- Neutrophils
- Endothelial cells
- Platelets
β Q4. What is the MOST IMPORTANT preformed cell-derived mediator?
A:
Histamine
β Q5. What are the actions of histamine? (EXAM FAVORITE)
A:
Histamine causes:
- Vasodilation
- Increased vascular permeability (endothelial contraction)
Released from:
- Mast cells (major source)
- Basophils
- Platelets
β Q6. What triggers histamine release?
A:
- Physical injury
- Immune reactions (IgE-mediated)
- Complement components (C3a, C5a)
- Neuropeptides
β Q7. What are arachidonic acid metabolites?
A:
Lipid mediators derived from cell membrane phospholipids via:
- Cyclooxygenase (COX)
- Lipoxygenase (LOX) pathways
β Q8. What are the MAJOR prostaglandins and their actions?

A:
- PGIβ (prostacyclin) β vasodilation, inhibits platelet aggregation
- PGEβ β pain, fever, vasodilation, permiability
- PGDβ β vasodilation, permeability
β Q9. What are leukotrienes and their effects? (EXAM CORE)
A:
- LTBβ β powerful neutrophil chemotaxis
- LTCβ, LTDβ, LTEβ β vasoconstriction, bronchospasm, β permeability
β Q10. What are lipoxins?
A:
Lipoxins are anti-inflammatory arachidonic acid derivatives that:
- Inhibit neutrophil recruitment
- Promote resolution
- lipoxin A4,B4
β Q11. What are cytokines?
A:
Low-molecular-weight proteins that coordinate inflammatory responses.
β Q12. Which cytokines are MOST important in inflammation? (EXAM FAVORITE)
A:
- TNF
- IL-1
- IL-6
β Q13. What are the major actions of TNF and IL-1?
A:
They cause:
- Endothelial activation
- Leukocyte recruitment
- Fever
- Acute-phase protein synthesis
- Cachexia (TNF)
β Q14. What are chemokines?
A:
A subset of cytokines that:
- Direct leukocyte chemotaxis
- Regulate leukocyte trafficking
Example:
- IL-8 β neutrophil chemotaxis(CXC)
β Q15. What is nitric oxide (NO) and its role?
A:
NO causes:
- Vasodilation
- Microbial killing
- Inhibition of platelet aggregation
Produced by:
- Endothelium
- Macrophages
β Q16. What are reactive oxygen species (ROS)?
A:
Short-lived oxygen radicals that:
- Kill microbes
- Cause host tissue damage when excessive
πΉ PLASMA-DERIVED MEDIATORS
β Q17. Which plasma protein systems generate inflammatory mediators?
A:
- Complement system
- Kinin system
- Coagulation system
- Fibrinolytic system
β Q18. What are the IMPORTANT complement components and actions? (EXAM CORE)
A:
- C3a, C5a β anaphylatoxins (vasodilation, permeability)
- C5a β chemotaxis, leukocyte activation
- C3b β opsonization
- MAC (C5b-9) β microbial lysis
β Q19. What is bradykinin and its actions?
A:
Bradykinin causes:
- Vasodilation
- Increased permeability
- Pain
β Q20. What is the KEY RULE about inflammatory mediators? (EXAM TRAP)
A:
Most mediators:
- Have short half-lives
- Act locally
- Are tightly regulated
Uncontrolled release β tissue damage.
π EXAM LOCK β ONE-LINE RECALL
Inflammatory mediators are short-lived cell- and plasma-derived molecules that regulate vascular changes, leukocyte recruitment, tissue injury, and resolution.
π§ CLINICAL CORRELATION (High-Yield)
- NSAIDs β inhibit COX β β prostaglandins
- Steroids β block phospholipase Aβ β β all arachidonic acid mediators
- Anti-TNF therapy β suppresses chronic inflammatory diseases
π§ SARR β SEGMENT 12
TOPIC: PATTERNS OF ACUTE INFLAMMATION β MORPHOLOGY, MECHANISM & EXAM TRAPS
Q1. What are βpatternsβ of acute inflammation?
A:
They are morphologic expressions of acute inflammation determined by:
- Severity of injury
- Type of tissue involved
- Nature of the inflammatory exudate
β Q2. What are the MAIN patterns of acute inflammation? (EXAM CORE)
A:
- Serous inflammation
- Fibrinous inflammation
- Suppurative (purulent) inflammation
- Ulcerative inflammation
πΉ 1. SEROUS INFLAMMATION
β Q3. What is serous inflammation?
A:
An acute inflammation characterized by thin, watery, cell-poor exudate derived from plasma or mesothelial secretions.
β Q4. Where is serous inflammation commonly seen?
A:
- Skin (e.g. burn blister)
- Serous cavities:
- Pleura
- Peritoneum
- Pericardium
β Q5. What is the mechanism of serous inflammation?
A:
- Mild increase in vascular permeability
- Minimal leukocyte involvement
πΉ 2. FIBRINOUS INFLAMMATION
β Q6. What is fibrinous inflammation?
A:
Inflammation with large amounts of fibrin in the exudate due to severe vascular permeability.
β Q7. Where is fibrinous inflammation typically seen?
A:
- Serosal surfaces:
- Pericardium
- Pleura
- Peritoneum
Classic example:
- Fibrinous pericarditis (βbread and butterβ appearance)
β Q8. What happens to fibrin in fibrinous inflammation?
A:
Two possibilities:
- Fibrinolysis β resolution
- Organization β fibrosis and adhesions
πΉ 3. SUPPURATIVE (PURULENT) INFLAMMATION
β Q9. What is suppurative inflammation?
A:
Inflammation characterized by production of pus, consisting of:
- Neutrophils
- Necrotic cells
- Edema fluid
β Q10. What organisms commonly cause suppuration?
A:
Pyogenic bacteria
(e.g. Staphylococcus)
β Q11. What is an abscess? (EXAM FAVORITE)
A:
A localized collection of pus within tissue, organ, or confined space.
β Q12. What is the fate of an abscess?
A:
- necrotic tissue debris in middle, neutrophils around it
- Surrounded by a fibrous wall
- Often requires surgical drainage
- Heals by fibrosis
πΉ 4. ULCERATIVE INFLAMMATION
β Q13. What is an ulcer?
A:
A local defect or excavation of the surface of an organ or tissue produced by sloughing of necrotic tissue.
β Q14. Where are ulcers commonly found?
A:
- Gastrointestinal tract
- Peptic ulcers
- Skin
- Pressure sores
- Oral cavity
- acute stage there is intense polymorphonuclear infiltration and vascular dilation in the margins of the defect.
- chronicity, the margins and base of the ulcer develop fibroblast proliferation, scarring, and the accumulation of lymphocytes, macrophages, and plasma cells.
β Q15. Why is ulceration important clinically?
A:
Because ulcers:
- May bleed
- May perforate
- Heal with scarring
- Can become chronic
π EXAM LOCK β PATTERN MEMORY
- Serous β watery, cell-poor
- Fibrinous β fibrin-rich, severe permeability
- Suppurative β pus, neutrophils
- Ulcer β surface necrosis and sloughing
π§ CLINICAL CORRELATION (High-Yield)
- Burn blister β serous inflammation
- Fibrinous pericarditis β friction rub
- Abscess β needs drainage, antibiotics alone insufficient
- Chronic ulcer β fibrosis, scarring
π§ SARR β SEGMENT 13
TOPIC: TISSUE REPAIR AFTER INFLAMMATION β REGENERATION vs SCARRING
β Q1. What happens to tissues after inflammation subsides?
A:
Tissues undergo repair, which occurs by:
- Regeneration
- Scarring (fibrosis)
Sometimes both occur together.
β Q2. What is regeneration?
A:
Regeneration is the replacement of injured tissue by the same type of cells, resulting in restoration of normal structure and function.
β Q3. Which tissues can regenerate? (EXAM CORE)
A:
- Labile tissues
- Epithelia (skin, GI mucosa)
- Hematopoietic cells
- Stable tissues (if framework intact) Arrest at G0
- Liver
- Kidney
- Endothelium
β Q4. What conditions are REQUIRED for regeneration?
A:
- Intact basement membrane
- Viable stem cells
- Minimal damage to connective tissue framework
β Q5. What is scarring (fibrosis)?
A:
Replacement of injured tissue by connective tissue (collagen) rather than parenchymal cells.
Results in:
- Structural support
- Loss of original function
β Q6. When does scarring occur? (EXAM FAVORITE)
A:
- Extensive tissue destruction
- Damage to connective tissue framework
- Injury to permanent cells
- Neurons
- Cardiac myocytes
β Q7. What are the KEY STEPS in scar formation?
A:
- Angiogenesis
- Fibroblast migration & proliferation
- Collagen deposition
- Tissue remodeling
β Q8. What role does inflammation play in repair?
A:
Inflammation:
- Clears necrotic tissue
- Provides growth factors
- Initiates repair
But prolonged inflammation:
- Impairs regeneration
- Promotes fibrosis
β Q9. What determines regeneration vs scarring? (DECISION LOGIC)
A:
- Tissue type
- Severity of injury
- Integrity of extracellular matrix
- Duration of inflammation
β Q10. Can regeneration and scarring occur together?
A:
Yes.
Example:
- Skin wounds β epithelial regeneration + dermal scar
π EXAM LOCK β ONE-LINE RECALL
After inflammation, tissues heal by regeneration if the framework is intact, or by scarring when damage is extensive or permanent cells are injured.
π§ CLINICAL CORRELATION (High-Yield)
- Myocardial infarction β scarring, no regeneration
- Liver injury β regeneration if framework intact
- Chronic inflammation β fibrosis and organ dysfunction
14 TOPIC: FACTORS AFFECTING INFLAMMATION & TISSUE REPAIR β SYSTEMIC + LOCAL
β Q1. Why do some wounds heal well while others do not?
A:
Because inflammation and repair are influenced by local and systemic factors that can enhance or impair healing.
β Q2. What are the TWO broad categories of factors affecting repair? (EXAM CORE)
A:
- Local factors
- Systemic factors
πΉ LOCAL FACTORS
β Q3. How does infection affect tissue repair?
A:
- Most important local cause of delayed healing
- Prolongs inflammation
- Increases tissue injury
- Interferes with repair processes
β Q4. How does poor blood supply affect repair?
A:
- Reduces oxygen delivery
- Impairs leukocyte function
- Decreases fibroblast activity
Example:
- Ischemic limbs heal poorly
β Q5. How do foreign bodies affect repair?
A:
- Sustain inflammation
- Prevent wound closure
- Increase risk of infection
β Q6. How does mechanical stress affect repair?
A:
- Excess movement disrupts healing tissue
- Can cause wound dehiscence
β Q7. How does wound size and type affect healing?
A:
- Larger wounds β more scarring
- Wounds in highly vascular tissues heal faster
πΉ SYSTEMIC FACTORS
β Q8. How does nutritional status affect repair? (EXAM FAVORITE)
A:
- Protein deficiency β β collagen synthesis
- Vitamin C deficiency β impaired collagen cross-linking
- Zinc deficiency β delayed epithelialization
β Q9. How does diabetes mellitus impair wound healing?
A:
- Microvascular disease β poor perfusion
- Impaired leukocyte function
- Increased susceptibility to infection
β Q10. How do glucocorticoids affect repair?
A:
- Suppress inflammation
- Inhibit fibroblast proliferation
- Decrease collagen synthesis
β Q11. How does age affect tissue repair?
A:
- Elderly β slower healing
- Reduced cell proliferation
- Decreased angiogenesis
β Q12. How do systemic illnesses affect repair?
A:
- Chronic diseases impair healing
- Examples:
- Anemia
- Renal failure
π EXAM LOCK β HIGH-YIELD LIST
- Infection β most important cause of delayed healing
- Poor perfusion β ischemia = poor repair
- Diabetes + steroids β impaired inflammation and repair
- Protein & vitamin C β essential for collagen
π§ CLINICAL CORRELATION (High-Yield)
- Diabetic foot ulcers β impaired healing + infection
- Steroid-treated patients β delayed wound repair
- Pressure sores β ischemia + necrosis
π§ SARR β ADD-ON SEGMENT: ANGIOGENESIS (New Vessel Formation)
TOPIC: ANGIOGENESIS β DEFINITION, STEPS, MEDIATORS, CLINICAL
β Q1. What is angiogenesis?
A:
Angiogenesis is the formation of new blood vessels from pre-existing vessels, mainly via endothelial cell sprouting.
β Q2. Why is angiogenesis important in pathology and healing?
A:
It is required for:
- Wound healing (granulation tissue)
- Repair after inflammation
- Tumor growth (tumors need new vessels)
- Collateral formation in ischemia
β Q3. What are the major steps of angiogenesis? (EXAM SEQUENCE)
A:
- Vasodilation and increased permeability
- Pericyte detachment from the vessel wall
- Basement membrane degradation
- Endothelial cell migration toward the angiogenic stimulus
- Endothelial cell proliferation
- Tube (lumen) formation
- Recruitment of periendothelial support cells
- Pericytes (capillaries)
- Smooth muscle cells (larger vessels)
- Basement membrane deposition and maturation
- Suppression of endothelial proliferation (stabilization)
β Q4. What mediates vasodilation in angiogenesis?
A:
Nitric oxide (NO) is a key mediator of vasodilation.
β Q5. What is the most important growth factor for angiogenesis?
A:
VEGF (vascular endothelial growth factor)
β Q6. What are the key actions of VEGF?
A:
VEGF causes:
- Endothelial cell proliferation
- Endothelial cell migration
- Vasodilation (via NO)
- Increased vascular permeability (very important early step)
β Q7. Which other growth factor is important in angiogenesis and why?
A:
FGF-2 (fibroblast growth factor-2) promotes:
- Endothelial proliferation
- Migration
- Vessel formation
β Q8. What breaks down the basement membrane to allow sprouting?
A:
Proteases, especially matrix metalloproteinases (MMPs), degrade:
- Basement membrane
- Extracellular matrix
This creates a pathway for endothelial migration.
β Q9. What is granulation tissue and why is it called that?
A:
Granulation tissue is the healing tissue composed of:
- Newly formed capillaries (angiogenesis)
- Proliferating fibroblasts
- Loose extracellular matrix
- Inflammatory cells (variable)
It looks βgranularβ because of many small new vessels.
β Q10. How do new vessels become stable and mature?
A:
They stabilize by:
- Recruitment of pericytes/smooth muscle
- Basement membrane deposition
- Reduced endothelial proliferation and permeability
π EXAM LOCK β ONE-LINE RECALL
Angiogenesis is VEGF-driven sprouting of new vessels from existing ones via endothelial migration, proliferation, tube formation, and maturation with pericyte recruitment and basement membrane deposition.
π§ CLINICAL CORRELATION (Concise)
- Tumors promote angiogenesis mainly through VEGF β allows growth and metastasis
- Anti-VEGF therapy can slow tumor vascular supply
- Diabetes/poor perfusion impairs angiogenesis β delayed wound healing
- Granulation tissue = angiogenesis + fibroblasts + loose ECM
π§ SARR β SEGMENT 16
TOPIC: FIBROBLAST ACTIVATION, COLLAGEN SYNTHESIS & ECM DEPOSITION
β Q1. What is the central cell in scar formation?
A:
The fibroblast.
It produces:
- Collagen
- Extracellular matrix (ECM) proteins
β Q2. What activates fibroblasts during tissue repair? (EXAM CORE)
A:
Growth factors released from:
- Macrophages
- Platelets
- Endothelial cells
Key mediators:
- TGF-Ξ² (most important)
- PDGF
- FGF
- IL-13
β Q3. What is the role of TGF-Ξ² in repair?
A:
TGF-Ξ²:
- Stimulates fibroblast proliferation
- Increases collagen synthesis
- Decreases ECM degradation
- Promotes fibrosis
β‘οΈ Central mediator of scarring.
β Q4. Which type of collagen is deposited first in wounds?
A:
Type III collagen (early, provisional).
Later replaced by Type I collagen.
β Q5. What other ECM components are deposited besides collagen?
A:
- Fibronectin
- Proteoglycans
- Hyaluronic acid
- Elastin (later)
β Q6. What balances ECM synthesis and degradation?
A:
- Matrix metalloproteinases (MMPs) β degrade ECM
- TIMPs (tissue inhibitors of metalloproteinases) β inhibit MMPs
π EXAM LOCK β ONE LINE
Fibroblast activation driven by TGF-Ξ² leads to collagen (III β I) and ECM deposition, forming the structural basis of scar tissue.
π§ SARR β SEGMENT 17
TOPIC: WOUND HEALING β PRIMARY vs SECONDARY INTENTION
β Q1. What is healing by primary intention?
A:
Healing of clean, uninfected wounds with closely approximated edges.
Example:
- Surgical incision
β Q2. What are the features of primary intention healing?
A:
- Minimal tissue loss
- Minimal inflammation
- Minimal granulation tissue
- Small scar
β Q3. What is healing by secondary intention?
A:
Healing of wounds with:
- Extensive tissue loss
- Widely separated edges
Example:
- Large ulcers
- Abscess cavities
β Q4. What are the features of secondary intention healing?
A:
- More inflammation
- Abundant granulation tissue
- Wound contraction
- Large scar
β Q5. What causes wound contraction? (EXAM FAVORITE)
A:
Myofibroblasts:
- Fibroblasts with smooth muscleβlike features
- Pull wound edges together
π EXAM LOCK β COMPARISON
- Primary intention β small wound, small scar
- Secondary intention β large wound, contraction, large scar
π§ SARR β SEGMENT 18
TOPIC: COMPLICATIONS OF WOUND HEALING (EXAM FAVORITES)
β Q1. What are the main categories of wound healing complications?
A:
- Deficient scar formation
- Excessive scar formation
- Contractures
πΉ DEFICIENT HEALING
β Q2. What causes wound dehiscence?
A:
- Inadequate collagen synthesis
- Increased wound stress
- Infection
- Poor perfusion
β‘οΈ Leads to wound reopening.
β Q3. What causes chronic ulceration?
A:
- Poor vascular supply
- Diabetes
- Persistent pressure
πΉ EXCESSIVE HEALING
β Q4. What is a hypertrophic scar?
A:
- Excess collagen deposition
- Scar remains within wound boundaries
- Often regresses with time
β Q5. What is a keloid? (VERY HIGH-YIELD)
A:
- Excessive collagen deposition
- Scar extends beyond wound margins
- Does not regress
- More common in:
- Dark-skinned individuals
- Earlobes, shoulders, sternum
β Q6. What is the collagen composition of keloids?
A:
- Increased Type III collagen
- Excess growth factor signaling (TGF-Ξ²)
πΉ CONTRACTURES
β Q7. What are contractures and where are they seen?
A:
- Exaggerated wound contraction
- Common after:
- Burns
- Palmar/plantar wounds
β‘οΈ Cause restricted movement.
π FINAL EXAM LOCK
Abnormal wound healing results from imbalance between collagen synthesis, degradation, and contraction, leading to dehiscence, hypertrophic scars, keloids, or contractures.